跳到主要导航 跳到搜索 跳到主要内容

The effects of diltiazem in renal transplantation patients treated with cyclosporine A

  • Wujun Xue
  • , Yong Song
  • , Puxun Tian
  • , Xiaoming Ding
  • , Xiaoming Pan
  • , Hang Yan
  • , Jun Hou
  • , Xinshun Feng
  • , Heli Xiang
  • , Xiaohui Tian
  • The First Affiliated Hospital of Xi’an Jiaotong University

科研成果: 期刊稿件 › 文章 › 同行评审

12 引用 (Scopus)

摘要

Objective: To investigate the effects of diltiazem and cyclosporine A (CsA) combination therapy on protecting the kidney, promoting graft functioning and improving post-transplanted kidney recovery. Methods: The blood concentrations of CsA, the condition of the post-transplant kidney, the rate of acute rejection (AR), as well as hepatic and renal toxicity in 636 cases of renal transplant recipients were determined after being treated by CsA, with or without diltiazem. Results: Compared with the control group which received CsA, mycophenolate mofetil (MMF) and prednisolone (Pred) but lacked diltiazem, the group receiving these agents together with diltiazem required reduced dosage of CsA (P < 0.01), while blood concentrations of CsA were significantly increased (P < 0.01); the recovery time of graft function was reduced from (6.2±1.5) d to (3.9±1.4) d (P < 0.01), and the rate of AR was decreased from 13.2% to 7.9% (P < 0.01). Conclusion: In renal transplantation patients treated with CsA and diltiazem, blood concentrations of CsA were increased while the dosage was decreased. This efficient combination therapy reduced patients' economic burden, at the same time retained kidney function, promoted graft function recovery and decreased hepatic and renal toxicity and the rate of AR.

源语言英语
页(从-至)317-323
页数7
期刊Journal of Biomedical Research
卷24
期4
DOI
出版状态已出版 - 7月 2010
已对外发布是

学术指纹

探究 'The effects of diltiazem in renal transplantation patients treated with cyclosporine A' 的科研主题。它们共同构成独一无二的学术指纹。

引用此